Loading…
Salvianolic Acid B Attenuates Hypertrophic Scar Formation In Vivo and In Vitro
Background Hypertrophic scars (HTSs) are a fibroproliferative disorder that occur following skin injuries. Salvianolic acid B (Sal-B) is an extractant from Salvia miltiorrhiza that has been reported to ameliorate fibrosis in multiple organs. However, the antifibrotic effect on HTSs remains unclear....
Saved in:
Published in: | Aesthetic plastic surgery 2023-08, Vol.47 (4), p.1587-1597 |
---|---|
Main Authors: | , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c375t-a804c96cd757499bc326381f5a6666c1f5e2f1eac6e45bfa63e420c12466c8193 |
---|---|
cites | cdi_FETCH-LOGICAL-c375t-a804c96cd757499bc326381f5a6666c1f5e2f1eac6e45bfa63e420c12466c8193 |
container_end_page | 1597 |
container_issue | 4 |
container_start_page | 1587 |
container_title | Aesthetic plastic surgery |
container_volume | 47 |
creator | Chong, Chio-Hou Sun, Jia-Ming Liu, Yu-Xin Tsai, Yi-Tung Zheng, Dan-Ning Zhang, Yi-Fan Yu, Li |
description | Background
Hypertrophic scars (HTSs) are a fibroproliferative disorder that occur following skin injuries. Salvianolic acid B (Sal-B) is an extractant from
Salvia miltiorrhiza
that has been reported to ameliorate fibrosis in multiple organs. However, the antifibrotic effect on HTSs remains unclear. This study aimed to determine the antifibrotic effect of Sal-B
in vitro
and
in vivo
.
Methods
In vitro
, hypertrophic scar-derived fibroblasts (HSFs) were isolated from human HTSs and cultured. HSFs were treated with (0, 10, 50, 100 μmol/L) Sal-B. Cell proliferation and migration were evaluated by EdU, wound healing, and transwell assays. The protein and mRNA levels of TGFβI, Smad2, Smad3, α-SMA, COL1, and COL3 were detected by Western blots and real-time PCR.
In vivo
, tension stretching devices were fixed on incisions for HTS formation. The induced scars were treated with 100 μL of Sal-B/PBS per day according to the concentration of the group and followed up for 7 or 14 days. The scar condition, collagen deposition, and α-SMA expression were analyzed by gross visual examination, H&E, Masson, picrosirius red staining, and immunofluorescence.
Results
In vitro,
Sal-B inhibited HSF proliferation, migration, and downregulated the expression of TGFβI, Smad2, Smad3, α-SMA, COL1, and COL3 in HSFs.
In vivo
, 50 and 100 μmol/L Sal-B significantly reduced scar size in gross and cross-sectional observations, with decreased α-SMA expression and collagen deposition in the tension-induced HTS model.
Conclusions
Our study demonstrated that Sal-B inhibits HSFs proliferation, migration, fibrotic marker expression and attenuates HTS formation in a tension-induced HTS model
in vivo
.
No Level Assigned
This journal requires that authors assign a level of evidence to each submission to which Evidence-Based Medicine rankings are applicable. This excludes Review Articles, Book Reviews, and manuscripts that concern Basic Science, Animal Studies, Cadaver Studies, and Experimental Studies. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors
www.springer.com/00266
. |
doi_str_mv | 10.1007/s00266-023-03279-1 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2779346317</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2843961453</sourcerecordid><originalsourceid>FETCH-LOGICAL-c375t-a804c96cd757499bc326381f5a6666c1f5e2f1eac6e45bfa63e420c12466c8193</originalsourceid><addsrcrecordid>eNp9kD9PwzAQxS0EoqXwBRiQJRaWgP_FTsZSUYpUwVBAbJbrOJAqsYudVOq3x5ACEgO33Envd-_sB8ApRpcYIXEVECKcJ4jQBFEi8gTvgSFmlCQpYXgfDBHlLCGYvwzAUQgrhDARgh2CAeUZRhklQ3C_UPWmUtbVlYZjXRXwGo7b1thOtSbA2XZtfOvd-i3KC608nDrfqLZyFt5Z-FxtHFS26OfIHYODUtXBnOz6CDxNbx4ns2T-cHs3Gc8TTUXaJipDTOdcFyIVLM-XmhJOM1ymisfScTCkxEZpbli6LBWnhhGkMWFRzXBOR-Ci9117996Z0MqmCtrUtbLGdUHGf-aUcYpFRM__oCvXeRtfJ0nGaM4xS2mkSE9p70LwppRrXzXKbyVG8jNt2actY9ryK22J49LZzrpbNqb4WfmONwK0B0KU7Kvxv7f_sf0AHp-IIw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2843961453</pqid></control><display><type>article</type><title>Salvianolic Acid B Attenuates Hypertrophic Scar Formation In Vivo and In Vitro</title><source>Springer Nature</source><creator>Chong, Chio-Hou ; Sun, Jia-Ming ; Liu, Yu-Xin ; Tsai, Yi-Tung ; Zheng, Dan-Ning ; Zhang, Yi-Fan ; Yu, Li</creator><creatorcontrib>Chong, Chio-Hou ; Sun, Jia-Ming ; Liu, Yu-Xin ; Tsai, Yi-Tung ; Zheng, Dan-Ning ; Zhang, Yi-Fan ; Yu, Li</creatorcontrib><description>Background
Hypertrophic scars (HTSs) are a fibroproliferative disorder that occur following skin injuries. Salvianolic acid B (Sal-B) is an extractant from
Salvia miltiorrhiza
that has been reported to ameliorate fibrosis in multiple organs. However, the antifibrotic effect on HTSs remains unclear. This study aimed to determine the antifibrotic effect of Sal-B
in vitro
and
in vivo
.
Methods
In vitro
, hypertrophic scar-derived fibroblasts (HSFs) were isolated from human HTSs and cultured. HSFs were treated with (0, 10, 50, 100 μmol/L) Sal-B. Cell proliferation and migration were evaluated by EdU, wound healing, and transwell assays. The protein and mRNA levels of TGFβI, Smad2, Smad3, α-SMA, COL1, and COL3 were detected by Western blots and real-time PCR.
In vivo
, tension stretching devices were fixed on incisions for HTS formation. The induced scars were treated with 100 μL of Sal-B/PBS per day according to the concentration of the group and followed up for 7 or 14 days. The scar condition, collagen deposition, and α-SMA expression were analyzed by gross visual examination, H&E, Masson, picrosirius red staining, and immunofluorescence.
Results
In vitro,
Sal-B inhibited HSF proliferation, migration, and downregulated the expression of TGFβI, Smad2, Smad3, α-SMA, COL1, and COL3 in HSFs.
In vivo
, 50 and 100 μmol/L Sal-B significantly reduced scar size in gross and cross-sectional observations, with decreased α-SMA expression and collagen deposition in the tension-induced HTS model.
Conclusions
Our study demonstrated that Sal-B inhibits HSFs proliferation, migration, fibrotic marker expression and attenuates HTS formation in a tension-induced HTS model
in vivo
.
No Level Assigned
This journal requires that authors assign a level of evidence to each submission to which Evidence-Based Medicine rankings are applicable. This excludes Review Articles, Book Reviews, and manuscripts that concern Basic Science, Animal Studies, Cadaver Studies, and Experimental Studies. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors
www.springer.com/00266
.</description><identifier>ISSN: 0364-216X</identifier><identifier>EISSN: 1432-5241</identifier><identifier>DOI: 10.1007/s00266-023-03279-1</identifier><identifier>PMID: 36810832</identifier><language>eng</language><publisher>New York: Springer US</publisher><subject>Evidence-based medicine ; Medicine ; Medicine & Public Health ; Original Article ; Otorhinolaryngology ; Plastic Surgery</subject><ispartof>Aesthetic plastic surgery, 2023-08, Vol.47 (4), p.1587-1597</ispartof><rights>Springer Science+Business Media, LLC, part of Springer Nature and International Society of Aesthetic Plastic Surgery 2023. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.</rights><rights>2023. Springer Science+Business Media, LLC, part of Springer Nature and International Society of Aesthetic Plastic Surgery.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c375t-a804c96cd757499bc326381f5a6666c1f5e2f1eac6e45bfa63e420c12466c8193</citedby><cites>FETCH-LOGICAL-c375t-a804c96cd757499bc326381f5a6666c1f5e2f1eac6e45bfa63e420c12466c8193</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36810832$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Chong, Chio-Hou</creatorcontrib><creatorcontrib>Sun, Jia-Ming</creatorcontrib><creatorcontrib>Liu, Yu-Xin</creatorcontrib><creatorcontrib>Tsai, Yi-Tung</creatorcontrib><creatorcontrib>Zheng, Dan-Ning</creatorcontrib><creatorcontrib>Zhang, Yi-Fan</creatorcontrib><creatorcontrib>Yu, Li</creatorcontrib><title>Salvianolic Acid B Attenuates Hypertrophic Scar Formation In Vivo and In Vitro</title><title>Aesthetic plastic surgery</title><addtitle>Aesth Plast Surg</addtitle><addtitle>Aesthetic Plast Surg</addtitle><description>Background
Hypertrophic scars (HTSs) are a fibroproliferative disorder that occur following skin injuries. Salvianolic acid B (Sal-B) is an extractant from
Salvia miltiorrhiza
that has been reported to ameliorate fibrosis in multiple organs. However, the antifibrotic effect on HTSs remains unclear. This study aimed to determine the antifibrotic effect of Sal-B
in vitro
and
in vivo
.
Methods
In vitro
, hypertrophic scar-derived fibroblasts (HSFs) were isolated from human HTSs and cultured. HSFs were treated with (0, 10, 50, 100 μmol/L) Sal-B. Cell proliferation and migration were evaluated by EdU, wound healing, and transwell assays. The protein and mRNA levels of TGFβI, Smad2, Smad3, α-SMA, COL1, and COL3 were detected by Western blots and real-time PCR.
In vivo
, tension stretching devices were fixed on incisions for HTS formation. The induced scars were treated with 100 μL of Sal-B/PBS per day according to the concentration of the group and followed up for 7 or 14 days. The scar condition, collagen deposition, and α-SMA expression were analyzed by gross visual examination, H&E, Masson, picrosirius red staining, and immunofluorescence.
Results
In vitro,
Sal-B inhibited HSF proliferation, migration, and downregulated the expression of TGFβI, Smad2, Smad3, α-SMA, COL1, and COL3 in HSFs.
In vivo
, 50 and 100 μmol/L Sal-B significantly reduced scar size in gross and cross-sectional observations, with decreased α-SMA expression and collagen deposition in the tension-induced HTS model.
Conclusions
Our study demonstrated that Sal-B inhibits HSFs proliferation, migration, fibrotic marker expression and attenuates HTS formation in a tension-induced HTS model
in vivo
.
No Level Assigned
This journal requires that authors assign a level of evidence to each submission to which Evidence-Based Medicine rankings are applicable. This excludes Review Articles, Book Reviews, and manuscripts that concern Basic Science, Animal Studies, Cadaver Studies, and Experimental Studies. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors
www.springer.com/00266
.</description><subject>Evidence-based medicine</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Original Article</subject><subject>Otorhinolaryngology</subject><subject>Plastic Surgery</subject><issn>0364-216X</issn><issn>1432-5241</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><recordid>eNp9kD9PwzAQxS0EoqXwBRiQJRaWgP_FTsZSUYpUwVBAbJbrOJAqsYudVOq3x5ACEgO33Envd-_sB8ApRpcYIXEVECKcJ4jQBFEi8gTvgSFmlCQpYXgfDBHlLCGYvwzAUQgrhDARgh2CAeUZRhklQ3C_UPWmUtbVlYZjXRXwGo7b1thOtSbA2XZtfOvd-i3KC608nDrfqLZyFt5Z-FxtHFS26OfIHYODUtXBnOz6CDxNbx4ns2T-cHs3Gc8TTUXaJipDTOdcFyIVLM-XmhJOM1ymisfScTCkxEZpbli6LBWnhhGkMWFRzXBOR-Ci9117996Z0MqmCtrUtbLGdUHGf-aUcYpFRM__oCvXeRtfJ0nGaM4xS2mkSE9p70LwppRrXzXKbyVG8jNt2actY9ryK22J49LZzrpbNqb4WfmONwK0B0KU7Kvxv7f_sf0AHp-IIw</recordid><startdate>20230801</startdate><enddate>20230801</enddate><creator>Chong, Chio-Hou</creator><creator>Sun, Jia-Ming</creator><creator>Liu, Yu-Xin</creator><creator>Tsai, Yi-Tung</creator><creator>Zheng, Dan-Ning</creator><creator>Zhang, Yi-Fan</creator><creator>Yu, Li</creator><general>Springer US</general><general>Springer Nature B.V</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>7X8</scope></search><sort><creationdate>20230801</creationdate><title>Salvianolic Acid B Attenuates Hypertrophic Scar Formation In Vivo and In Vitro</title><author>Chong, Chio-Hou ; Sun, Jia-Ming ; Liu, Yu-Xin ; Tsai, Yi-Tung ; Zheng, Dan-Ning ; Zhang, Yi-Fan ; Yu, Li</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c375t-a804c96cd757499bc326381f5a6666c1f5e2f1eac6e45bfa63e420c12466c8193</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Evidence-based medicine</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Original Article</topic><topic>Otorhinolaryngology</topic><topic>Plastic Surgery</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Chong, Chio-Hou</creatorcontrib><creatorcontrib>Sun, Jia-Ming</creatorcontrib><creatorcontrib>Liu, Yu-Xin</creatorcontrib><creatorcontrib>Tsai, Yi-Tung</creatorcontrib><creatorcontrib>Zheng, Dan-Ning</creatorcontrib><creatorcontrib>Zhang, Yi-Fan</creatorcontrib><creatorcontrib>Yu, Li</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>MEDLINE - Academic</collection><jtitle>Aesthetic plastic surgery</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Chong, Chio-Hou</au><au>Sun, Jia-Ming</au><au>Liu, Yu-Xin</au><au>Tsai, Yi-Tung</au><au>Zheng, Dan-Ning</au><au>Zhang, Yi-Fan</au><au>Yu, Li</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Salvianolic Acid B Attenuates Hypertrophic Scar Formation In Vivo and In Vitro</atitle><jtitle>Aesthetic plastic surgery</jtitle><stitle>Aesth Plast Surg</stitle><addtitle>Aesthetic Plast Surg</addtitle><date>2023-08-01</date><risdate>2023</risdate><volume>47</volume><issue>4</issue><spage>1587</spage><epage>1597</epage><pages>1587-1597</pages><issn>0364-216X</issn><eissn>1432-5241</eissn><abstract>Background
Hypertrophic scars (HTSs) are a fibroproliferative disorder that occur following skin injuries. Salvianolic acid B (Sal-B) is an extractant from
Salvia miltiorrhiza
that has been reported to ameliorate fibrosis in multiple organs. However, the antifibrotic effect on HTSs remains unclear. This study aimed to determine the antifibrotic effect of Sal-B
in vitro
and
in vivo
.
Methods
In vitro
, hypertrophic scar-derived fibroblasts (HSFs) were isolated from human HTSs and cultured. HSFs were treated with (0, 10, 50, 100 μmol/L) Sal-B. Cell proliferation and migration were evaluated by EdU, wound healing, and transwell assays. The protein and mRNA levels of TGFβI, Smad2, Smad3, α-SMA, COL1, and COL3 were detected by Western blots and real-time PCR.
In vivo
, tension stretching devices were fixed on incisions for HTS formation. The induced scars were treated with 100 μL of Sal-B/PBS per day according to the concentration of the group and followed up for 7 or 14 days. The scar condition, collagen deposition, and α-SMA expression were analyzed by gross visual examination, H&E, Masson, picrosirius red staining, and immunofluorescence.
Results
In vitro,
Sal-B inhibited HSF proliferation, migration, and downregulated the expression of TGFβI, Smad2, Smad3, α-SMA, COL1, and COL3 in HSFs.
In vivo
, 50 and 100 μmol/L Sal-B significantly reduced scar size in gross and cross-sectional observations, with decreased α-SMA expression and collagen deposition in the tension-induced HTS model.
Conclusions
Our study demonstrated that Sal-B inhibits HSFs proliferation, migration, fibrotic marker expression and attenuates HTS formation in a tension-induced HTS model
in vivo
.
No Level Assigned
This journal requires that authors assign a level of evidence to each submission to which Evidence-Based Medicine rankings are applicable. This excludes Review Articles, Book Reviews, and manuscripts that concern Basic Science, Animal Studies, Cadaver Studies, and Experimental Studies. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors
www.springer.com/00266
.</abstract><cop>New York</cop><pub>Springer US</pub><pmid>36810832</pmid><doi>10.1007/s00266-023-03279-1</doi><tpages>11</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0364-216X |
ispartof | Aesthetic plastic surgery, 2023-08, Vol.47 (4), p.1587-1597 |
issn | 0364-216X 1432-5241 |
language | eng |
recordid | cdi_proquest_miscellaneous_2779346317 |
source | Springer Nature |
subjects | Evidence-based medicine Medicine Medicine & Public Health Original Article Otorhinolaryngology Plastic Surgery |
title | Salvianolic Acid B Attenuates Hypertrophic Scar Formation In Vivo and In Vitro |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-12T18%3A17%3A47IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Salvianolic%20Acid%20B%20Attenuates%20Hypertrophic%20Scar%20Formation%20In%20Vivo%20and%20In%20Vitro&rft.jtitle=Aesthetic%20plastic%20surgery&rft.au=Chong,%20Chio-Hou&rft.date=2023-08-01&rft.volume=47&rft.issue=4&rft.spage=1587&rft.epage=1597&rft.pages=1587-1597&rft.issn=0364-216X&rft.eissn=1432-5241&rft_id=info:doi/10.1007/s00266-023-03279-1&rft_dat=%3Cproquest_cross%3E2843961453%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c375t-a804c96cd757499bc326381f5a6666c1f5e2f1eac6e45bfa63e420c12466c8193%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2843961453&rft_id=info:pmid/36810832&rfr_iscdi=true |